A detailed history of State Of Wisconsin Investment Board transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 64,133 shares of FDMT stock, worth $566,294. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,133
Previous 59,529 7.73%
Holding current value
$566,294
Previous $1.25 Million 44.52%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.81 - $27.22 $49,769 - $125,320
4,604 Added 7.73%
64,133 $693,000
Q2 2024

Aug 14, 2024

BUY
$20.93 - $30.01 $698,831 - $1 Million
33,389 Added 127.73%
59,529 $1.25 Million
Q1 2024

May 14, 2024

SELL
$17.03 - $35.87 $291,962 - $614,955
-17,144 Reduced 39.61%
26,140 $832,000
Q4 2023

Feb 12, 2024

SELL
$9.76 - $21.25 $86,834 - $189,061
-8,897 Reduced 17.05%
43,284 $876,000
Q3 2023

Nov 14, 2023

BUY
$12.64 - $19.76 $216,346 - $338,212
17,116 Added 48.81%
52,181 $664,000
Q2 2023

Aug 14, 2023

BUY
$15.16 - $23.26 $282,051 - $432,752
18,605 Added 113.03%
35,065 $633,000
Q1 2023

May 15, 2023

BUY
$15.45 - $23.19 $48,822 - $73,280
3,160 Added 23.76%
16,460 $282,000
Q4 2022

Feb 14, 2023

SELL
$6.85 - $25.46 $283,836 - $1.05 Million
-41,436 Reduced 75.7%
13,300 $295,000
Q3 2022

Nov 14, 2022

BUY
$6.96 - $11.48 $195,054 - $321,727
28,025 Added 104.92%
54,736 $440,000
Q2 2022

Aug 15, 2022

SELL
$5.68 - $15.99 $59,577 - $167,719
-10,489 Reduced 28.2%
26,711 $186,000
Q1 2022

May 13, 2022

BUY
$13.16 - $22.64 $67,116 - $115,464
5,100 Added 15.89%
37,200 $562,000
Q4 2021

Feb 11, 2022

BUY
$19.56 - $32.94 $377,508 - $635,742
19,300 Added 150.78%
32,100 $704,000
Q3 2021

Nov 12, 2021

BUY
$22.73 - $36.04 $91,238 - $144,664
4,014 Added 45.69%
12,800 $345,000
Q2 2021

Aug 12, 2021

BUY
$22.2 - $42.29 $195,049 - $371,559
8,786 New
8,786 $212,000

Others Institutions Holding FDMT

About 4D Molecular Therapeutics, Inc.


  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $286M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.